《韩国药典》KP9.0英文版电子版下载Monographs Part I (J-Z) Korean Pharmacopoeia.pdf

上传人:wj 文档编号:10502331 上传时间:2023-02-15 格式:PDF 页数:471 大小:10.21MB
下载 相关 举报
《韩国药典》KP9.0英文版电子版下载Monographs Part I (J-Z) Korean Pharmacopoeia.pdf_第1页
第1页 / 共471页
《韩国药典》KP9.0英文版电子版下载Monographs Part I (J-Z) Korean Pharmacopoeia.pdf_第2页
第2页 / 共471页
《韩国药典》KP9.0英文版电子版下载Monographs Part I (J-Z) Korean Pharmacopoeia.pdf_第3页
第3页 / 共471页
《韩国药典》KP9.0英文版电子版下载Monographs Part I (J-Z) Korean Pharmacopoeia.pdf_第4页
第4页 / 共471页
《韩国药典》KP9.0英文版电子版下载Monographs Part I (J-Z) Korean Pharmacopoeia.pdf_第5页
第5页 / 共471页
点击查看更多>>
下载资源
资源描述

《韩国药典》KP9.0英文版电子版下载Monographs Part I (J-Z) Korean Pharmacopoeia.pdf

《《韩国药典》KP9.0英文版电子版下载Monographs Part I (J-Z) Korean Pharmacopoeia.pdf》由会员分享,可在线阅读,更多相关《《韩国药典》KP9.0英文版电子版下载Monographs Part I (J-Z) Korean Pharmacopoeia.pdf(471页珍藏版)》请在冰豆网上搜索。

《韩国药典》KP9.0英文版电子版下载Monographs Part I (J-Z) Korean Pharmacopoeia.pdf

JosamycinPropionateCHCH3OH3CHOOHCH3OHHHCH3JosamycinPropionateisaderivativeofjosamycin.JosamycinPropionatecontainsnotlessthan843g(potency)permgofjosamycin(C42H69NO15:

828.00),calculatedonthedriedbasis.DescriptionJosamycinPropionateisawhitetolightyellowishwhitecrystallinepowder,andisodorlessandtasteless.JosamycinPropionateisverysolubleinmethanolorinethanol,solubleinether,andpracticallyinsolubleinwater.Identification(l)Dissolve2mgofJosamycinPro-pionatein5mLofsulfuricacid:

thesolutionturnstored-brown.

(2)DeterminetheabsorptionspectrumofasolutionofJosamycinPropionateinmethanol(lin100000)asdirectedunderUltraviolet-visibleSpectrophotometry,itexhibitsmaximumbetween230nmand233nm.PurityHeavymetals-Proceedwith1.0gofJosamy-cinPropionateaccordingtoMethod2andperformthetest.Preparethecontrolsolutionwith3.0mLofstan-dardleadsolution(notmorethan30ppm).LossonDryingNotmorethan2.0%(0.5g,inva-cuum,60C,3hours).ResidueonignitionNotmorethan0.2%(1g).AssayTheCylinder-platemethodmethod(l)Agarmediaforseedandbaselayer-UsethemediuminI2l)

(1)CDunderMicrobialAssayforAntibiotics.

(2)Testorganism-BacillussubtilisATCC6633.(3)Weighaccuratelyabout20mg(potency)ofJo-samycinPropionate,dissolvein10mLofmethanol,andadd0.06mol/Lphosphatebuffersolution,pH5.6tomakesolutionsothateachmLcontains400.0g(potency).Takeexactlyasuitableamountofthissolu-tion,add0.06mol/Lphosphatebuffersolution,pH5.6tomakesolutionssothateachmLcontains80.0g(potency)and20.0g(potency),andusethesesolu-tionsasthehighconcentrationtestsolutionandthelowconcentrationtestsolution,respectively.Separately,weighaccuratelyabout20mgofJosamycinPropionateKP9539RS,dissolveinl0mLofmethanol,andadd0.06mol/Lphosphatebuffersolution,pH5.6tomakesolutionsothateachmLcontains400.0g(potency),andusethissolutionasthestandardstocksolution.Keepthestan-dardstocksolutionatnotexceeding5Candusewith-in3days.Takeexactlyasuitableamountofthestan-dardstocksolutionbeforeuse,add0.06mol/Lphos-phatebuffersolution,pH5.6tomakesolutionssothateachmLcontains80.0g(potency)and20.0g(po-tency),andusethesesolutionsasthehighconcentra-tionstandardsolutionandthelowconcentrationstan-dardsolution,respectively.PerformthetestwiththesesolutionsaccordingtotheCylinder-platemethod(I8)asdirectedunderMicrobialAssayforAntibiotics.PackagingandStoragePreserveintightcontainers.KanamycinMonosulfateKanamycinMonosulfateisthesulfateofanaminogly-cosidesubstancehavingantibacterialactivityproducedbythegrowthofStreptomyceskanamyceticus.KanamycinMonosulfatecontainsnotlessthan750g(potency)permgofkanamycin(C18H36N4O11:

484.50),calculatedonthedriedbasis.DescriptionKanamycinMonosulfateisawhitetoyellowishwhitepowder,isodorlessorhasalittlebitofodor,andhasalittlebitofbittertaste.KanamycinMonosulfateisfreelysolubleinwater,andpracticallyinsolubleinethanolorinether.Identification

(1)To50mgofKanamycinMonosul-fateadd3mLofwateranddissolve,andadd2mLofanthroneTS:

ablue-purplecolordevelops.

(2)To20mgofKanamycinMonosulfate,add2mLof0.06mol/Lphosphatebuffersolution,pH5.6,dis-solve,andaddlmLofninhydrinTSandboil:

ablue-purplecolordevelops.(3)To10mgofKanamycinMonosulfateadd1mLofwateranddissolve,andaddlmLofninhydrinsolu-tioninn-butanol(1in500)and0.5mLofpyridine,_andheatinwaterbathfor5minutesandaddlmLofwater:

adarkpurplecolordevelops.(4)AsolutionofKanamycinMonosulfateresponds540Monographs.PartItoQualitativeTestsforsulfatesalt.pHThepHofasolutionobtainedbydissolving0.1gofKanamycinMonosulfatein10mLofwaterisbe-tween6.5and8.5.SterilityTestItmeetstherequirement,whenKana-mycinMonosulfateisusedinasterilepreparation.BacterialEndotoxinsLessthan0.50EUpermgofkanamycin,whenKanamycinMonosulfateisusedinasterilepreparation.LossonDryingNotmorethan4.0%(0.1g,inva-cuum,60C,3hours).ResidueonIgnitionNotmorethan1.0%(1g).AssayTheCylinder-platemethodmethod

(1)Agarmediaforseedandbaselayer-UsethemediuminI21)

(1)CDunderMicrobialAssayforAntibiotics.

(2)Testorganism-BacillussubtilisATCC6633.(3)Weighaccuratelyabout20mg(potency)ofKa-namycinMonosulfate,dissolveinsterilepurifiedwater,tomakeasolutionsothateachmLcontains400.0g(potency),andusethissolutionastheteststocksolu-tion.Takeexactlyasuitableamountofthissolution,add0.1mol/Lphosphatebuffersolution,pH8.0tomakesolutionssothateachmLcontains20.0g(po-tency)and5.0g(potency),andusethesesolutionsasthehighconcentrationtestsolutionandthelowconcen-trationtestsolution,respectively.Separately,weighac-curatelyabout20mgofKanamycinSulfateRS,pre-viouslydried,dissolvein0.05mol/Lphosphatebuffersolution,pH6.0tomakesolutionsothateachmLcon-tains400.0g(potency),andusethissolutionasthestandardstocksolution.Keepthestandardstocksolu-tionbetween5Cand15C,andusewithin30days.Takeexactlyasuitableamountofthestandardstocksolutionbeforeuse,add0.1mol/Lphosphatebufferso-lution,pH8.0tomakesolutionssothateachmLcon-tains20.0g(potency)and5.0g(potency),andusethesesolutionsasthehighconcentrationstandardsolu-tionandthelowconcentrationstandardsolution,re-spectively.Performthetestwiththesesolutionsaccord-ingtotheCylinder-platemethod(I8)asdirectedunderMicrobialAssayforAntibiotics.PackagingandStoragePreserveintightcontainers.KanamycinSulfateKanamycinSulfateisthesulfateofanaminoglycosidesubstancehavingantibacterialactivityproducedbythegrowthofStreptomyceskanamyceticus.KanamycinSulfateispreparedbyaddingnotmorethan1molofsulfuricacidto1molofkanamycinmonosul-fate.KanamycinSulfatecontainsnotlessthan600g(po-tency)permgofkanamycin(C18H35N4O11:

484.50),calculatedonthedriedbasis.DescriptionKanamycinSulfateisawhitetoyello-wishwhitepowder,isodorlessorhasalittlebitofodor,andhasalittlebitofbittertaste.KanamycinSulfateisverysolubleinwater,andpracti-callyinsolubleinethanol,inacetone,orinether.IdentificationPerformthetestaccordingtoIdentifi-cationin_KanamycinMonosulfate.pHThepHofasolutionobtainedbydissolving0.5gofKanamycinMonosulfatein10mLofwaterisbe-tween6.0and8.5.SterilityTestItmeetstherequirement,whenKana-mycinSulfateisusedinasterilepreparation.PyrogenTestItmeetstherequirement,whenKana-mycinSulfateisusedinasterilepreparation,.WeighanappropriateamountofKanamycinSulfate,dissolveinwater,makethesolutionsothateachmLcontains10.0mg,andusethesolutionasthetestsolution.Theamountofinjectionis1.0mLofthetestsolutionperkgofbodyweightofrabbit.LossonDryingNotmorethan5.0%(0.1g,inva-cuum,60C,3hours).AssayPerformthetestaccordingtoAssayin_Kana-mycinMonosulfate.Weighaccuratelyabout20mg(potency)ofKanamycinSulfate,dissolveinsterilepu-rifiedwatertomakeasolutionsothateachmLcon-tains400.0g(potency),andusethissolutionastheteststocksolution.Takeexactlyasuitableamountofthissolution,add0.1mol/Lphosphatebuffersolution,pH8.0tomakesolutionssothateachmLcontains20.0g(potency)and5.0g(potency),andusethesesolu-tionsasthehighconcentrationtestsolutionandthelowconcentrationtestsolution,respectively.PackagingandStoragePreserveintightcontainers.KainicAcidH(NC02HHAT:

H2C02HH20H2C=CRICH3KainicAcid,previouslydried,containsnotlessthan99.0%andnotmorethan101.0%ofkainicacid(C10H1sNO4:

213.23).DescriptionKainicAcidiswhitecrystalsorcrystal-linepowder,isodorlessandhasanacidtaste.KainicAcidissparinglysolubleinwaterorinwarmwater,veryslightlysolubleinglacialaceticacidorinethanolandpracticallyinsolubleinether.KainicaciddissolvesindilutehydrochloricacidorinsodiumhydroxideTS.Meltingpoint-About252C(withdecomposition).pH-ThepHofasolutionofKainicAcid(1in100)isbetween2.8and3.5.Identification

(1)To5mLofasolutionofKainicAcid(1in5000),add1mLofninhydrinTSandwarminawater-bathatatemperaturebetween60Cand70Cfor5minutes:

ayellowcolorisproduced.

(2)Dissolve50mgofKainicAcidin5mLofgla-cialaceticacidandadd0.5mLofbromineTS:

thecol-orofbrominedisappearsimmediately.SpecificOpticalRotationa0:

Between-13and-17(0.5g,water,50mL,200mm).Purity

(1)Clarityandcolorofsolution-Dissolve0.10gofKainicAcidin10mLofwater:

thesolutionisclearandcolorless.

(2)Chloride-Take0.5gofKainicAcidinaplati-numcrucible,dissolvein5mLofsodiumcarbonateTSandevaporateInawater-bathtodryness.Heatthecruc-ibleslowlyatfirstandthenigniteuntilthesampleisalmostincinerated.Aftercooling,add12mLofdilutenitricacidtotheresidue,dissolvebywarmingandfilter.Washtheresiduewith15mLofwater,combinethewashingsandthefiltrateandaddwatertomake50mL.KP9541Performthetest(notmorethan0.021%).Controlsolution-Add5mLofsodiumcarbonateTSto0.30mLof0.01mol/LhydrochloricacidVSandproceedasdirectedabove.(3)Sulfate-Dissolve0.5gofKainicAcidin40mLofwaterbywarming.Cool,add1mLofdilutehy-drochloricacidandwatertomake50mLandperformthetest.Preparethecontrolsolutionwith0.30mLof0.005mol/LsulfuricacidVS(notmorethan0.028%).(4)Ammonium-Take0.25gofKainicAcidandperformthetest.Preparethecontrolsolutionwith5.0mLofstandardammoniumsolution(notmorethan0.02%).(5)Heavymetals-Proceedwith1.0gofKainicAcidaccordingto

展开阅读全文
相关资源
猜你喜欢
相关搜索

当前位置:首页 > 经管营销 > 经济市场

copyright@ 2008-2022 冰豆网网站版权所有

经营许可证编号:鄂ICP备2022015515号-1